Transurethral Vapor Ablation in Patients with Intermediate-Risk Localized Prostate Cancer.

Saved in:
Bibliographic Details
Title: Transurethral Vapor Ablation in Patients with Intermediate-Risk Localized Prostate Cancer.
Authors: Dixon CM; WMC Health Good Samaritan Hospital, Bon Secours Urology, Suffern, New York, USA., Levin RM; Chesapeake Urology, Baltimore and Annapolis, Maryland, USA., Cantrill CH; Urology San Antonio Research, San Antonio, Texas, USA., Regelman M; Minnesota Urology, Woodbury, Minnesota, USA., Spilseth B; University of Minnesota, Departments of Urology and Radiology, Minneapolis, Minnesota, USA., Tutrone RF Jr; Chesapeake Urology, Baltimore and Annapolis, Maryland, USA., White MA; Urology San Antonio Research, San Antonio, Texas, USA., Milbank AJ; Minnesota Urology, Woodbury, Minnesota, USA., Warlick CA; University of Minnesota, Departments of Urology and Radiology, Minneapolis, Minnesota, USA.
Source: Journal of endourology [J Endourol] 2023 Feb; Vol. 37 (2), pp. 225-232. Date of Electronic Publication: 2022 Nov 22.
Publication Type: Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Mary Ann Liebert Country of Publication: United States NLM ID: 8807503 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-900X (Electronic) Linking ISSN: 08927790 NLM ISO Abbreviation: J Endourol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1557-900X
DOI:10.1089/end.2022.0452